Piramal Pharma (NSE:PPLPHARMA) Scaled Net Operating Assets : N/A (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Piramal Pharma's operating assets for the quarter that ended in Mar. 2024 was ₹146,687 Mil. Piramal Pharma's operating liabilities for the quarter that ended in Mar. 2024 was ₹26,903 Mil. Piramal Pharma's Total Assets for the quarter that ended in Dec. 2023 was ₹0 Mil. Therefore, Piramal Pharma's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was N/A.

Piramal Pharma Scaled Net Operating Assets Historical Data

The historical data trend for Piramal Pharma's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Scaled Net Operating Assets Chart

Piramal Pharma Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Scaled Net Operating Assets

0.71

1.81

0.91

0.83

Piramal Pharma Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Scaled Net Operating Assets	Get a 7-Day Free Trial							-	-	-	-	-

Competitive Comparison of Piramal Pharma's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Piramal Pharma's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Piramal Pharma's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Piramal Pharma's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Piramal Pharma's Scaled Net Operating Assets falls into.

Piramal Pharma Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Piramal Pharma's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Mar. 2024 )
=	(Operating Assets (A: Mar. 2024 )	-	Operating Liabilities (A: Mar. 2024 ))	/	Total Assets (A: Mar. 2023 )
=	(146686.7	-	26902.8)	/	145225.6
=	0.82

where

	Operating Assets		(A: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	153118.1	-	6431.4
=	146686.7

	Operating Liabilities		(A: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	74004.4	-	26017.4	-	21084.2
=	26902.8

Piramal Pharma's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2024 )
=	(Operating Assets (Q: Mar. 2024 )	-	Operating Liabilities (Q: Mar. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(146686.7	-	26902.8)	/	0
=	N/A

where

	Operating Assets		(Q: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	153118.1	-	6431.4
=	146686.7

	Operating Liabilities		(Q: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	74004.4	-	26017.4	-	21084.2
=	26902.8

Piramal Pharma Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Piramal Pharma (NSE:PPLPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » Scaled Net Operating Assets

Traded in Other Exchanges

543635:India

Address

Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070

Website

https://www.piramal.com

Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (NSE:PPLPHARMA) Headlines

No Headlines